Portal infusion of tumor necrosis factor increases mortality in rats

Michael P. Kahky, Craig O. Daniel, Anatolio B. Cruz, Harold V. Gaskill

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Tumor necrosis factor (TNF) is a protein found in the serum of mice presensitized with BCG following injection of endotoxin. Although TNF has been shown to cause hemorrhagic necrosis of certain tumors, the marked toxicity of recombinant human TNF has limited the clinical usefulness of this compound. This experiment was designed to determine whether hepatic metabolism would reduce the systemic toxicity of TNF delivered by the portal circulation. Twenty male Fischer rats received a continuous infusion of recombinant human TNF (100 μg/kg/day), 10 through a portal venous branch, and 10 through a branch of the inferior vena cava. Control animals received an infusion of carrier solution by the same route. After 7 days the animals were sacrificed and their organs weighed and sectioned. Mortality in the portal TNF group was 100%. The animals followed the clinical pattern seen with lethal TNF injection. Histologic sections revealed significant gastric and small intestinal mucosal injury, pulmonary edema, and acute tubular necrosis. Animals receiving TNF systemically lost more weight per day of infusion than controls, but followed a relatively benign course. Systemically infused animals had evidence of mild pulmonary edema, and a periportal mononuclear infiltrate in the liver, but no obvious renal or gastrointestinal injury. In a second experiment the effect of escalating doses of portal TNF infusion on liver enzymes was assessed. TNF was infused intraportally at 10, 50, or 100 μg/kg/day for 3 days. Control animals received a carrier solution. Mortality was dose-related with 100% mortality in animals receiving 100 μg/kg/day, and 40% mortality in the 50 μg/kg/day group. Animals receiving TNF had lower protein and albumin levels when compared to controls, but serum levels of hepatocellular enzymes were normal in all groups. We conclude that administration of TNF by the portal venous route carries significant toxicity and results in increased mortality. Portal venous infusion of TNF appears to potentiate the toxic effects of the hormone and may explain the increased mortality seen in these animals. There was no evidence for direct hepatocellular toxicity.

Original languageEnglish (US)
Pages (from-to)138-145
Number of pages8
JournalJournal of Surgical Research
Issue number2
StatePublished - Aug 1990
Externally publishedYes

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Portal infusion of tumor necrosis factor increases mortality in rats'. Together they form a unique fingerprint.

Cite this